Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2119/molmed.2015.00055 http://scihub22266oqcxt.onion/10.2119/molmed.2015.00055 C4661055!4661055!26605643     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Mol+Med 2015 ; 21 (Suppl 1): S19-24 Nephropedia Template TP {{tp|p=26605643|t=2015. 25 Years On: A Retrospective on Migration Inhibitory Factor in Tumor Angiogenesis |pdf=|usr=}}{{26605643}} gab.com Text 25 Years On: A Retrospective on Migration Inhibitory Factor in Tumor Angiogenesis JO: Mol Med http://www.kidney.de/pget.php?&tw=1&pmid=26605643 #FOAvip Twenty-five years ago marked the publication of the first report describing a functional contribution by the cytokine, macrophage migration inhibitory factor (MIF), to tumor-associated angiogenesis and growth. Since first appearing, this report has been cited 304 times (as of this writing), underscoring not only the importance of this landmark study but also the importance of MIF in tumor neovascularization. Perhaps more importantly, this first link between MIF and stromal cell?dependent tumor angiogenesis presaged the subsequent identification of MIF in mediating protumorigenic contributions to several solid tumor stromal cell types, including monocytes, macrophages, T lymphocytes, NK cells, fibroblasts, endothelial progenitors and mesenchymal stem cells. This retrospective review will broadly evaluate both past and present literature stemming from this initial publication, with an emphasis on cellular sources, cellular effectors, signal transduction mechanisms and the clinical importance of MIF-dependent tumor vascularization. Twit Text FOAVip 25 Years On: A Retrospective on Migration Inhibitory Factor in Tumor Angiogenesis ????Mol Med http://www.kidney.de/pget.php?&tw=1&pmid=26605643 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26605643 #FOAvip English Wikipedia <ref>{{Cite pmid|26605643}}</ref> 25 Years On: A Retrospective on Migration Inhibitory Factor in Tumor Angiogenesis #MMPMID26605643 Chesney JA; Mitchell RA Mol Med 2015[]; 21 (Suppl 1): S19-24 PMID26605643show ga Twenty-five years ago marked the publication of the first report describing a functional contribution by the cytokine, macrophage migration inhibitory factor (MIF), to tumor-associated angiogenesis and growth. Since first appearing, this report has been cited 304 times (as of this writing), underscoring not only the importance of this landmark study but also the importance of MIF in tumor neovascularization. Perhaps more importantly, this first link between MIF and stromal cell?dependent tumor angiogenesis presaged the subsequent identification of MIF in mediating protumorigenic contributions to several solid tumor stromal cell types, including monocytes, macrophages, T lymphocytes, NK cells, fibroblasts, endothelial progenitors and mesenchymal stem cells. This retrospective review will broadly evaluate both past and present literature stemming from this initial publication, with an emphasis on cellular sources, cellular effectors, signal transduction mechanisms and the clinical importance of MIF-dependent tumor vascularization. ä25 Years On: A Retrospective on Migration Inhibitory Factor in Tumor A(epmc).pdf DeepDyve Pubget Overpricing